Logo image of HLNE

HAMILTON LANE INC-CLASS A (HLNE) Stock Fundamental Analysis

NASDAQ:HLNE - Nasdaq - US4074971064 - Common Stock - Currency: USD

156.32  +4.67 (+3.08%)

After market: 156.32 0 (0%)

Fundamental Rating

7

HLNE gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 225 industry peers in the Capital Markets industry. Both the health and profitability get an excellent rating, making HLNE a very profitable company, without any liquidiy or solvency issues. HLNE is valued quite expensive, but it does show an excellent growth. These ratings would make HLNE suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year HLNE was profitable.
HLNE had a positive operating cash flow in the past year.
HLNE had positive earnings in each of the past 5 years.
Each year in the past 5 years HLNE had a positive operating cash flow.
HLNE Yearly Net Income VS EBIT VS OCF VS FCFHLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

1.2 Ratios

HLNE has a Return On Assets of 13.53%. This is amongst the best in the industry. HLNE outperforms 93.15% of its industry peers.
Looking at the Return On Equity, with a value of 33.16%, HLNE belongs to the top of the industry, outperforming 97.26% of the companies in the same industry.
The Return On Invested Capital of HLNE (20.87%) is better than 97.72% of its industry peers.
HLNE had an Average Return On Invested Capital over the past 3 years of 19.34%. This is significantly above the industry average of 6.81%.
The 3 year average ROIC (19.34%) for HLNE is below the current ROIC(20.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.53%
ROE 33.16%
ROIC 20.87%
ROA(3y)10.77%
ROA(5y)10.68%
ROE(3y)32.12%
ROE(5y)34.97%
ROIC(3y)19.34%
ROIC(5y)20.09%
HLNE Yearly ROA, ROE, ROICHLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

1.3 Margins

HLNE has a Profit Margin of 31.13%. This is in the better half of the industry: HLNE outperforms 71.23% of its industry peers.
In the last couple of years the Profit Margin of HLNE has grown nicely.
HLNE has a Operating Margin of 45.75%. This is in the better half of the industry: HLNE outperforms 78.54% of its industry peers.
In the last couple of years the Operating Margin of HLNE has remained more or less at the same level.
Industry RankSector Rank
OM 45.75%
PM (TTM) 31.13%
GM N/A
OM growth 3Y-0.86%
OM growth 5Y1.44%
PM growth 3Y-2.38%
PM growth 5Y13.8%
GM growth 3YN/A
GM growth 5YN/A
HLNE Yearly Profit, Operating, Gross MarginsHLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

The number of shares outstanding for HLNE has been increased compared to 1 year ago.
The number of shares outstanding for HLNE has been increased compared to 5 years ago.
Compared to 1 year ago, HLNE has an improved debt to assets ratio.
HLNE Yearly Shares OutstandingHLNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
HLNE Yearly Total Debt VS Total AssetsHLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

HLNE has an Altman-Z score of 8.67. This indicates that HLNE is financially healthy and has little risk of bankruptcy at the moment.
HLNE has a better Altman-Z score (8.67) than 94.06% of its industry peers.
The Debt to FCF ratio of HLNE is 1.07, which is an excellent value as it means it would take HLNE, only 1.07 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.07, HLNE belongs to the best of the industry, outperforming 87.21% of the companies in the same industry.
HLNE has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
HLNE's Debt to Equity ratio of 0.45 is fine compared to the rest of the industry. HLNE outperforms 71.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 1.07
Altman-Z 8.67
ROIC/WACCN/A
WACCN/A
HLNE Yearly LT Debt VS Equity VS FCFHLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

HLNE has a Current Ratio of 1.24. This is a normal value and indicates that HLNE is financially healthy and should not expect problems in meeting its short term obligations.
HLNE has a Current ratio (1.24) which is comparable to the rest of the industry.
A Quick Ratio of 1.24 indicates that HLNE should not have too much problems paying its short term obligations.
HLNE's Quick ratio of 1.24 is in line compared to the rest of the industry. HLNE outperforms 54.79% of its industry peers.
HLNE does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 1.24
HLNE Yearly Current Assets VS Current LiabilitesHLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 48.86% over the past year.
The Earnings Per Share has been growing by 15.47% on average over the past years. This is quite good.
HLNE shows a strong growth in Revenue. In the last year, the Revenue has grown by 41.16%.
HLNE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.04% yearly.
EPS 1Y (TTM)48.86%
EPS 3Y12.82%
EPS 5Y15.47%
EPS Q2Q%76.06%
Revenue 1Y (TTM)41.16%
Revenue growth 3Y17.48%
Revenue growth 5Y17.04%
Sales Q2Q%34.33%

3.2 Future

Based on estimates for the next years, HLNE will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.12% on average per year.
Based on estimates for the next years, HLNE will show a quite strong growth in Revenue. The Revenue will grow by 17.12% on average per year.
EPS Next Y29.69%
EPS Next 2Y16.56%
EPS Next 3Y16.27%
EPS Next 5Y15.12%
Revenue Next Year32.91%
Revenue Next 2Y19.85%
Revenue Next 3Y17.62%
Revenue Next 5Y17.12%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
HLNE Yearly Revenue VS EstimatesHLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
HLNE Yearly EPS VS EstimatesHLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 30.00, the valuation of HLNE can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of HLNE indicates a slightly more expensive valuation: HLNE is more expensive than 72.60% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 29.98. HLNE is around the same levels.
HLNE is valuated quite expensively with a Price/Forward Earnings ratio of 29.35.
Based on the Price/Forward Earnings ratio, HLNE is valued a bit more expensive than the industry average as 72.15% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of HLNE to the average of the S&P500 Index (22.66), we can say HLNE is valued slightly more expensively.
Industry RankSector Rank
PE 30
Fwd PE 29.35
HLNE Price Earnings VS Forward Price EarningsHLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HLNE indicates a somewhat cheap valuation: HLNE is cheaper than 63.47% of the companies listed in the same industry.
HLNE's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 41.03
EV/EBITDA 34.27
HLNE Per share dataHLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
HLNE has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as HLNE's earnings are expected to grow with 16.27% in the coming years.
PEG (NY)1.01
PEG (5Y)1.94
EPS Next 2Y16.56%
EPS Next 3Y16.27%

4

5. Dividend

5.1 Amount

HLNE has a Yearly Dividend Yield of 1.29%.
Compared to an average industry Dividend Yield of 8.75, HLNE is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.30, HLNE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.29%

5.2 History

The dividend of HLNE is nicely growing with an annual growth rate of 26.37%!
HLNE has been paying a dividend for over 5 years, so it has already some track record.
As HLNE did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)26.37%
Div Incr Years7
Div Non Decr Years7
HLNE Yearly Dividends per shareHLNE Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

34.06% of the earnings are spent on dividend by HLNE. This is a low number and sustainable payout ratio.
HLNE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP34.06%
EPS Next 2Y16.56%
EPS Next 3Y16.27%
HLNE Yearly Income VS Free CF VS DividendHLNE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
HLNE Dividend Payout.HLNE Dividend Payout, showing the Payout Ratio.HLNE Dividend Payout.PayoutRetained Earnings

HAMILTON LANE INC-CLASS A

NASDAQ:HLNE (2/28/2025, 8:00:01 PM)

After market: 156.32 0 (0%)

156.32

+4.67 (+3.08%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-04 2025-02-04/bmo
Earnings (Next)05-21 2025-05-21/amc
Inst Owners69.26%
Inst Owner Change4.4%
Ins Owners3.13%
Ins Owner Change-3.31%
Market Cap11.20B
Analysts53.33
Price Target175.61 (12.34%)
Short Float %3.27%
Short Ratio3.5
Dividend
Industry RankSector Rank
Dividend Yield 1.29%
Yearly Dividend1.21
Dividend Growth(5Y)26.37%
DP34.06%
Div Incr Years7
Div Non Decr Years7
Ex-Date03-14 2025-03-14 (0.49)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.96%
Min EPS beat(2)-3.63%
Max EPS beat(2)11.55%
EPS beat(4)3
Avg EPS beat(4)19.11%
Min EPS beat(4)-3.63%
Max EPS beat(4)34.99%
EPS beat(8)5
Avg EPS beat(8)8.98%
EPS beat(12)8
Avg EPS beat(12)9.64%
EPS beat(16)12
Avg EPS beat(16)14.1%
Revenue beat(2)1
Avg Revenue beat(2)0.53%
Min Revenue beat(2)-3.38%
Max Revenue beat(2)4.44%
Revenue beat(4)3
Avg Revenue beat(4)13.58%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)26.94%
Revenue beat(8)4
Avg Revenue beat(8)5.9%
Revenue beat(12)6
Avg Revenue beat(12)9.72%
Revenue beat(16)8
Avg Revenue beat(16)7.92%
PT rev (1m)3.8%
PT rev (3m)-10.1%
EPS NQ rev (1m)-0.86%
EPS NQ rev (3m)-2.66%
EPS NY rev (1m)3.04%
EPS NY rev (3m)2.11%
Revenue NQ rev (1m)-0.44%
Revenue NQ rev (3m)-0.47%
Revenue NY rev (1m)1.53%
Revenue NY rev (3m)1.39%
Valuation
Industry RankSector Rank
PE 30
Fwd PE 29.35
P/S 16.19
P/FCF 41.03
P/OCF 39.53
P/B 17.25
P/tB 17.25
EV/EBITDA 34.27
EPS(TTM)5.21
EY3.33%
EPS(NY)5.33
Fwd EY3.41%
FCF(TTM)3.81
FCFY2.44%
OCF(TTM)3.95
OCFY2.53%
SpS9.66
BVpS9.06
TBVpS9.06
PEG (NY)1.01
PEG (5Y)1.94
Profitability
Industry RankSector Rank
ROA 13.53%
ROE 33.16%
ROCE 26.45%
ROIC 20.87%
ROICexc 28.54%
ROICexgc 29.5%
OM 45.75%
PM (TTM) 31.13%
GM N/A
FCFM 39.46%
ROA(3y)10.77%
ROA(5y)10.68%
ROE(3y)32.12%
ROE(5y)34.97%
ROIC(3y)19.34%
ROIC(5y)20.09%
ROICexc(3y)21.93%
ROICexc(5y)22.96%
ROICexgc(3y)23.08%
ROICexgc(5y)24.14%
ROCE(3y)24.51%
ROCE(5y)25.46%
ROICexcg growth 3Y13.41%
ROICexcg growth 5Y-9.75%
ROICexc growth 3Y12.7%
ROICexc growth 5Y-9.54%
OM growth 3Y-0.86%
OM growth 5Y1.44%
PM growth 3Y-2.38%
PM growth 5Y13.8%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 1.07
Debt/EBITDA 0.9
Cap/Depr 108.93%
Cap/Sales 1.49%
Interest Coverage 250
Cash Conversion 86.92%
Profit Quality 126.78%
Current Ratio 1.24
Quick Ratio 1.24
Altman-Z 8.67
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)117.78%
Cap/Depr(5y)203.85%
Cap/Sales(3y)1.73%
Cap/Sales(5y)2.64%
Profit Quality(3y)128.03%
Profit Quality(5y)149.17%
High Growth Momentum
Growth
EPS 1Y (TTM)48.86%
EPS 3Y12.82%
EPS 5Y15.47%
EPS Q2Q%76.06%
EPS Next Y29.69%
EPS Next 2Y16.56%
EPS Next 3Y16.27%
EPS Next 5Y15.12%
Revenue 1Y (TTM)41.16%
Revenue growth 3Y17.48%
Revenue growth 5Y17.04%
Sales Q2Q%34.33%
Revenue Next Year32.91%
Revenue Next 2Y19.85%
Revenue Next 3Y17.62%
Revenue Next 5Y17.12%
EBIT growth 1Y49.82%
EBIT growth 3Y16.47%
EBIT growth 5Y18.73%
EBIT Next Year42.52%
EBIT Next 3Y21.67%
EBIT Next 5Y22.56%
FCF growth 1Y20.55%
FCF growth 3Y-13.33%
FCF growth 5Y0.67%
OCF growth 1Y22.94%
OCF growth 3Y-13.73%
OCF growth 5Y1.61%